Literature DB >> 24723472

Top-down proteomics in health and disease: challenges and opportunities.

Zachery R Gregorich1, Ying Ge.   

Abstract

Proteomics is essential for deciphering how molecules interact as a system and for understanding the functions of cellular systems in human disease; however, the unique characteristics of the human proteome, which include a high dynamic range of protein expression and extreme complexity due to a plethora of PTMs and sequence variations, make such analyses challenging. An emerging "top-down" MS-based proteomics approach, which provides a "bird's eye" view of all proteoforms, has unique advantages for the assessment of PTMs and sequence variations. Recently, a number of studies have showcased the potential of top-down proteomics for the unraveling of disease mechanisms and discovery of new biomarkers. Nevertheless, the top-down approach still faces significant challenges in terms of protein solubility, separation, and the detection of large intact proteins, as well as underdeveloped data analysis tools. Consequently, new technological developments are urgently needed to advance the field of top-down proteomics. Herein, we intend to provide an overview of the recent applications of top-down proteomics in biomedical research. Moreover, we will outline the challenges and opportunities facing top-down proteomics strategies aimed at understanding and diagnosing human diseases.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Human disease; Mass spectrometry; PTMs; Proteomics; Systems biology

Mesh:

Substances:

Year:  2014        PMID: 24723472      PMCID: PMC4100610          DOI: 10.1002/pmic.201300432

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  130 in total

1.  Proteomics: biology in the post-genomic era. Companies all over the world rush to lead the way in the new post-genomics race.

Authors:  V Brower
Journal:  EMBO Rep       Date:  2001-07       Impact factor: 8.807

Review 2.  Proteomics: the first decade and beyond.

Authors:  Scott D Patterson; Ruedi H Aebersold
Journal:  Nat Genet       Date:  2003-03       Impact factor: 38.330

3.  Identification of post-translational modifications by blind search of mass spectra.

Authors:  Dekel Tsur; Stephen Tanner; Ebrahim Zandi; Vineet Bafna; Pavel A Pevzner
Journal:  Nat Biotechnol       Date:  2005-11-27       Impact factor: 54.908

4.  Electron transfer dissociation mass spectrometry of hemoglobin on clinical samples.

Authors:  Didia Coelho Graça; Pierre Lescuyer; Lorella Clerici; Yury O Tsybin; Ralf Hartmer; Markus Meyer; Kaveh Samii; Denis F Hochstrasser; Alexander Scherl
Journal:  J Am Soc Mass Spectrom       Date:  2012-08-07       Impact factor: 3.109

Review 5.  Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Proteomics approaches to the systems biology of cardiovascular diseases.

Authors:  Thomas A Drake; Peipei Ping
Journal:  J Lipid Res       Date:  2006-10-25       Impact factor: 5.922

Review 6.  Regulation of cardiac contractile function by troponin I phosphorylation.

Authors:  Joanne Layland; R John Solaro; Ajay M Shah
Journal:  Cardiovasc Res       Date:  2005-04-01       Impact factor: 10.787

7.  Protein signatures for survival and recurrence in metastatic melanoma.

Authors:  William M Hardesty; Mark C Kelley; Deming Mi; Robert L Low; Richard M Caprioli
Journal:  J Proteomics       Date:  2011-04-23       Impact factor: 4.044

8.  Application of metal-coded affinity tags (MeCAT): absolute protein quantification with top-down and bottom-up workflows by metal-coded tagging.

Authors:  U Bergmann; R Ahrends; B Neumann; C Scheler; M W Linscheid
Journal:  Anal Chem       Date:  2012-05-31       Impact factor: 6.986

9.  Analysis of human C1q by combined bottom-up and top-down mass spectrometry: detailed mapping of post-translational modifications and insights into the C1r/C1s binding sites.

Authors:  Delphine Pflieger; Cédric Przybylski; Florence Gonnet; Jean-Pierre Le Caer; Thomas Lunardi; Gérard J Arlaud; Régis Daniel
Journal:  Mol Cell Proteomics       Date:  2009-12-14       Impact factor: 5.911

10.  Mass spectrometric immunoassay.

Authors:  R W Nelson; J R Krone; A L Bieber; P Williams
Journal:  Anal Chem       Date:  1995-04-01       Impact factor: 6.986

View more
  70 in total

1.  MASH Suite Pro: A Comprehensive Software Tool for Top-Down Proteomics.

Authors:  Wenxuan Cai; Huseyin Guner; Zachery R Gregorich; Albert J Chen; Serife Ayaz-Guner; Ying Peng; Santosh G Valeja; Xiaowen Liu; Ying Ge
Journal:  Mol Cell Proteomics       Date:  2015-11-23       Impact factor: 5.911

2.  Top-Down Proteomics of Large Proteins up to 223 kDa Enabled by Serial Size Exclusion Chromatography Strategy.

Authors:  Wenxuan Cai; Trisha Tucholski; Bifan Chen; Andrew J Alpert; Sean McIlwain; Takushi Kohmoto; Song Jin; Ying Ge
Journal:  Anal Chem       Date:  2017-05-02       Impact factor: 6.986

3.  Simultaneous Quantification of Protein Expression and Modifications by Top-down Targeted Proteomics: A Case of the Sarcomeric Subproteome.

Authors:  Ziqing Lin; Liming Wei; Wenxuan Cai; Yanlong Zhu; Trisha Tucholski; Stanford D Mitchell; Wei Guo; Stephen P Ford; Gary M Diffee; Ying Ge
Journal:  Mol Cell Proteomics       Date:  2018-12-27       Impact factor: 5.911

4.  Distinct sequences and post-translational modifications in cardiac atrial and ventricular myosin light chains revealed by top-down mass spectrometry.

Authors:  Zachery R Gregorich; Wenxuan Cai; Ziqing Lin; Albert J Chen; Ying Peng; Takushi Kohmoto; Ying Ge
Journal:  J Mol Cell Cardiol       Date:  2017-04-17       Impact factor: 5.000

5.  Comprehensive Characterization of AMP-Activated Protein Kinase Catalytic Domain by Top-Down Mass Spectrometry.

Authors:  Deyang Yu; Ying Peng; Serife Ayaz-Guner; Zachery R Gregorich; Ying Ge
Journal:  J Am Soc Mass Spectrom       Date:  2016-02       Impact factor: 3.109

Review 6.  Top-down mass spectrometry of cardiac myofilament proteins in health and disease.

Authors:  Ying Peng; Serife Ayaz-Guner; Deyang Yu; Ying Ge
Journal:  Proteomics Clin Appl       Date:  2014-08       Impact factor: 3.494

7.  Middle-Down Multi-Attribute Analysis of Antibody-Drug Conjugates with Electron Transfer Dissociation.

Authors:  Bifan Chen; Ziqing Lin; Yanlong Zhu; Yutong Jin; Eli Larson; Qingge Xu; Cexiong Fu; Zhaorui Zhang; Qunying Zhang; Wayne A Pritts; Ying Ge
Journal:  Anal Chem       Date:  2019-09-06       Impact factor: 6.986

8.  New mass-spectrometry-compatible degradable surfactant for tissue proteomics.

Authors:  Ying-Hua Chang; Zachery R Gregorich; Albert J Chen; Leekyoung Hwang; Huseyin Guner; Deyang Yu; Jianyi Zhang; Ying Ge
Journal:  J Proteome Res       Date:  2015-01-30       Impact factor: 4.466

Review 9.  Identification and Quantification of Proteoforms by Mass Spectrometry.

Authors:  Leah V Schaffer; Robert J Millikin; Rachel M Miller; Lissa C Anderson; Ryan T Fellers; Ying Ge; Neil L Kelleher; Richard D LeDuc; Xiaowen Liu; Samuel H Payne; Liangliang Sun; Paul M Thomas; Trisha Tucholski; Zhe Wang; Si Wu; Zhijie Wu; Dahang Yu; Michael R Shortreed; Lloyd M Smith
Journal:  Proteomics       Date:  2019-05       Impact factor: 3.984

Review 10.  Top-down Proteomics: Technology Advancements and Applications to Heart Diseases.

Authors:  Wenxuan Cai; Trisha M Tucholski; Zachery R Gregorich; Ying Ge
Journal:  Expert Rev Proteomics       Date:  2016-07-26       Impact factor: 3.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.